Friedman S, Vila G, Even C, Timsit J, Boitard C, Dardennes R, Guelfi J D, Mouren-Simeoni M C
Clinique des Maladies Mentales et de l'Encéphale (CMME), Centre Hospitalier Sainte-Anne, Universi;té René Descartes Paris V, UFR Cochin Port-Royal, 1 rue Cabanis, 75674 Paris Cedex 14, France.
J Psychosom Res. 2003 Sep;55(3):285-7. doi: 10.1016/s0022-3999(02)00636-0.
To assess the prevalence of alexithymia in insulin-dependent diabetic mellitus (IDDM) outpatients. To examine whether alexithymia is associated with diabetic somatic variables, depression, and compliance.
Our sample comprised 69 diabetic outpatients followed in a university hospital. We assessed the prevalence of alexithymia (26-item Toronto Alexithymia Scale, TAS-26) and the relationships among alexithymia, depression (13-item Beck Depression Inventory, BDI-13), somatic diabetic variables (glycosylated hemoglobin, number of mild or severe hypoglycemia, somatic complications), and compliance (observer-rater scale completed by diabetologist).
The prevalence of alexithymia in IDDM patients was low (14.4%). Alexithymia and depression, as measured by TAS-26 and BDI-13 scores, respectively, correlated with each other. Alexithymia was not correlated with glycemic control, somatic complications, or compliance.
In our sample, alexithymia was related to depression and not to somatic factors or compliance.
评估胰岛素依赖型糖尿病（IDDM）门诊患者述情障碍的患病率。研究述情障碍是否与糖尿病躯体变量、抑郁及依从性相关。
我们的样本包括在一家大学医院随访的69例糖尿病门诊患者。我们评估了述情障碍的患病率（采用26项多伦多述情障碍量表，TAS - 26）以及述情障碍、抑郁（采用13项贝克抑郁量表，BDI - 13）、糖尿病躯体变量（糖化血红蛋白、轻度或重度低血糖发作次数、躯体并发症）和依从性（由糖尿病专家完成的观察者评分量表）之间的关系。
IDDM患者中述情障碍的患病率较低（14.4%）。分别用TAS - 26和BDI - 13评分衡量的述情障碍和抑郁相互相关。述情障碍与血糖控制、躯体并发症或依从性无关。
在我们的样本中，述情障碍与抑郁相关，而与躯体因素或依从性无关。
